Advertisement

Topics

Latest "PayChest Arranges Financing" News Stories

12:25 EDT 23rd October 2018 | BioPortfolio

Here are the most relevant search results for "PayChest Arranges Financing" found in our extensive news archives from over 250 global news sources.

More Information about PayChest Arranges Financing on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about PayChest Arranges Financing for you to read. Along with our medical data and news we also list PayChest Arranges Financing Clinical Trials, which are updated daily. BioPortfolio also has a large database of PayChest Arranges Financing Companies for you to search.

Showing "PayChest Arranges Financing" News Articles 1–25 of 9,900+

Tuesday 23rd October 2018

Oncogenex Pharmaceuticals Inc ACHV Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

SummaryOncogenex Pharmaceuticals Inc OncoGenex formerly known as Sonus Pharmaceuticals Inc, is a drug discovery and development company that develops and commercializes therapies and mechaisms for addressing treatment resistance in cancer patients. The company's products include custirsen and apatorsen. Its custirsen drug is designed to block the production of clusterin, a cytoprotective protein w...


Ping An Good Doctor Launches China's First Online AI TCM Smart Listening Diagnosis

SHANGHAI, Oct. 23, 2018 /PRNewswire/ -- China's leading one-stop healthcare ecosystem platform, Ping An Good Doctor (the "Company", stock code: 1833.HK), today announced the online launch of its traditional Chinese medicine ("TCM") Smart Listening Diagnosis, the first in China and developed independently by the Company. As an important part of the Modern Physician Hua Tuo ...

CromaPharma GmbH Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13082018] Prices from USD $250

SummaryCromaPharma GmbH Croma Pharma is a pharmaceutical company that offers development and commercialization of drugs in the field of aesthetic dermatology. The company's products include princess skincare, princess injectables, and princess lift products. Its princess skincare products comprise princess skincare masks and princess skincare serums. Croma Pharma's princess lift products include h...


Aeglea BioTherapeutics Inc AGLE Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 07092018] Prices from USD $250

SummaryAeglea BioTherapeutics Inc Aeglea BioTherapeutics, formerly Aeglea BioTherapeutics Holdings, LLC is a biotechnology company that develops and commercializes engineered human enzymes for the treatment of cancer and rare genetic diseases. The company's product pipeline comprises AEB1102, AEB3103, AEB2109, and AEB4104. It develops engineered human enzymes to target and degrade amino acids in t...

DiscoveRx Corp Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 11102018] Prices from USD $250

SummaryDiscoveRx Corp DiscoveRx is a developer, manufacturer, and commercialize of reagents. The company offers cellbased assay kits, profiling and screening services and other solutions for drug discovery, screening, and life science markets. The company's products include cellbased assay kits, ligands and inhibitors, detection reagents, biochemical and 2nd messenger assays, reagents and consumab...

Translate Bio Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24072018] Prices from USD $250

SummaryTranslate Bio Inc Translate Bio, formerly RaNA Therapeutics Inc is a healthcare service provider that develops therapies which targets RNA within cells in the body to selectively activate protein expression. The company provides platform oligonucleotides oligos are molecules designed to target specific areas of RNA. Its platform uses two distinct approaches to activate RNA during transcript...

HitGen LTD Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 28072018] Prices from USD $350

HitGen LTD Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's HitGen LTD Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by HitGen LTD since Jan...

Yungjin Pharm Co Ltd 003520 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12102018] Prices from USD $250

SummaryYungjin Pharm Co Ltd Yungjin, a subsidiary of KTG Corp is a pharmaceutical company that develops, manufactures and distributes active pharmaceutical ingredients, formulations and tonic drinks. The company provides API products such as cephalosporins and other general products. It also offers cefaclor cap and dry syr, cefadroxil monohydrate, cefalexin monohydrate, cefamandole inj, cefcapene ...

Colorado State University Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12102018] Prices from USD $250

SummaryColorado State University CSU is a research university that offers various academic programs. The university offers graduate degree programs, undergraduate degree programs, research programs, summer programs and honor programs. Its schools and programs include graduate school, international programs, school of education, school of global environmental sustainability, and school of social wo...

LBC Credit Partners Supports the Recapitalization of Employee-Owned AirBorn, Inc.

PHILADELPHIA, Oct. 23, 2018 /PRNewswire/ -- LBC Credit Partners ("LBC") a leading provider of financing solutions to middle market companies, provided a $60.0 million senior Read more...

AccessOne Survey Finds 27% of Families Delay Medical Care Due to Costs

Survey finds families struggle with limited payment options for medical bills; twice as likely to have accounts sent to collections Twenty-seven percent of households with children are likely to delay care because they can’t afford to pay for it, according to a new survey commissioned by AccessOne, a leading provider of patient fi

McKesson Corp MCK Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12102018] Prices from USD $250

SummaryMcKesson Corp McKesson is a provider of healthcare services and information technology solutions. It distributes pharmaceuticals, medical equipment, and health and beauty care products in North America and overseas. The company also develops and provides decision support software and systems to assist clinicians and physicians in clinical diagnosis and treatment. McKesson offers medicines, ...

Emcure Pharmaceuticals Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

SummaryEmcure Pharmaceuticals Ltd Emcure develops, manufactures and markets a range of pharmaceutical products worldwide. The company specializes in the development and manufacture of differentiated pharmaceutical products. It also manufactures active pharmaceutical ingredients APIs primarily for use in manufacturing of pharmaceutical products. Emcure has presence in all major therapeutic areas in...

Synthego Receives $110M in Funding to Accelerate Global Access to Genome Engineering

REDWOOD CITY, Calif., Oct. 23, 2018 /PRNewswire/ — Synthego, a leading genome engineering innovation company, today announced a $110 million Series C financing round led by Founders Fund with additional investment from existing investors 8VC and Menlo Ventures. This brings Synthego’s […] The post Synthego Receives $110M in Funding to Accelerate Global Access to Genome Engineerin...

Odonate Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2018

Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer, today announced financial results for the three and nine months ended September 30, 2018. As of September 30, 2018, Odonate had $161.0 million in cash, compared ...

Pharmsynthez LIFE Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

SummaryPharmsynthez is a pharmaceutical company that manufactures and distributes generic active pharmaceutical ingredients API. The company manufactures scienceintensive substances, chemicals and officinal medicines. It offers drugs such as vazostenon, glaumax, cathalin, mizoprostol, nevir, unusable, pencrofton, segydrine, fenasid and fuldurabel. Pharmsynthez's products are used in oncology, gyne...

Thermo Fisher Scientific Inc TMO Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12102018] Prices from USD $250

SummaryThermo Fisher Scientific Inc Thermo Fisher is a provider of equipment, analytical instruments, reagents and consumables, software and services to tackle complex analytical challenges in research, diagnostics and clinical laboratories. It offers solutions for cellular analysis and biology, flow cytometry and synthetic biology. The company's product portfolio includes technologies for mass sp...

Adventist Health System Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24092018] Prices from USD $250

SummaryAdventist Health System AHS is a faith based medical health care organization. It serves through hospitals, nursing facilities and home care agencies. The organization, through its technologies and clinical research provide general medical care and specialized care for more than four million patients every year. AHS provides various healthcare services such as cardiology center, diabetes, b...

Stoke Therapeutics Announces $90M Series B Financing to Advance Novel Oligonucleotide Medicines ⁦@StokeTx⁩ https://www.businesswire.com/news/home/20181023005249/en/Stoke-Therapeutics-Announces-90-Million-Series-Financing …

Stoke Therapeutics Announces $90M Series B Financing to Advance Novel Oligonucleotide Medicines ⁦ @StokeTx⁩ https://www.businesswire.com/news/home/20181023005249/en/Stoke-Therapeutics-Announces-90-Million-Series-Financing …

Genzyme Corp Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12102018] Prices from USD $250

SummaryGenzyme Corp Genzyme, a subsidiary of Sanofi, is a biotechnology company that develops specialty care treatments targeting rare diseases, oncology, immunology and multiple sclerosis. It offers products for the treatment of indications including various forms of cancer, mucopolysaccharidosis I, multiple sclerosis, Gaucher disease type 1, longterm enzyme replacement therapy, acute lymphoblast...

Oncology startup TP Therapeutics raises $80m in financing

New investors HBM Healthcare Investments (Cayman) and Nextech Invest also took part in the mezzanine financing, said TP Therapeutics. The new capital secured by the clinical-stage precision oncology The post Oncology startup TP Therapeutics raises $80m in financing appeared first on Pharma Business review.

Stoke Therapeutics Announces $90 Million Series B Financing to Advance Novel Oligonucleotide Medicines

Lead candidate to treat the genetic cause of Dravet Syndrome expected to reach clinic by 2020 Stoke Therapeutics today announced that it has completed a $90 million Series B financing to advance its pipeline of antisense oligonucleotide medicines for Dravet Syndrome and other severe genetic diseases. The financing round was led by RTW I...

Icon Bioscience Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

SummaryIcon Bioscience Inc IBI is a provider of ophthalmic pharmaceuticals. The company uses its proprietary Verisome extendedrelease drug delivery platform for the development of unique intraocular eyecare therapeutics. Its product pipeline comprises cataract surgery inflammation, DME, glaucoma, PDR and wet AMD, uveitis and dry AMD and retinoblastoma drugs. IBI's verisome technology is a novel dr...

Cidara Therapeutics Inc CDTX Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27082018] Prices from USD $250

SummaryCidara Therapeutics Inc Cidara, formerly K2 Therapeutics Inc is a biotechnology company that discovers, develops and commercializes novel antiinfectives including immunotherapies. The company's pipeline products include novel echinocandin CD101 IV, for the treatment of systemic candida infections; CD201, a bispecific antimicrobial immunotherapy that is being developed for multidrug resistan...

Compugen Ltd CGEN Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12102018] Prices from USD $250

SummaryCompugen Ltd Compugen is a predictive drug discovery and development company that develops medicines for immunooncology and autoimmune diseases. The company's immunooncology pipeline comprises COM701 and PVRIG, BAY 1905254, COM902 and TIGIT; and CGENXXXX/Myeloid and autoimmune diseases pipeline includes CGEN15001 and ILDR2Fc Fusion. Its drug development process includes target discovery, ta...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks